EU approves Boston Scientific stent Promus Element
Boston Scientific secured European approval for its Promus Element drug-coated stent, which is made of an alloy that offers more flexibility than older stents. The company expects the FDA to approve the device by 2012.
Boston Globe, The | 11/02
This story published in AdvaMed SmartBrief on 11/03/2009
More from SmartBrief:
Analysts: Boston Scientific might resolve ICD issue in 30 days
Thursday, March 18, 2010
Boston Scientific gets FDA approval for iliac stent system
Friday, March 12, 2010
Boston Scientific to invest about $30M in R&D project in Ireland
Monday, July 13, 2009
Get stories like these delivered daily for FREE:
|
AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more |
|